TP53 and neoplasm: The study explored the underlying mechanism of the anti‐tumour function of CDO1, and found that CDO1 activated the p53 signalling pathway and inhibited the PI3K/AKT signalling pathway in MDA‐MB‐231 and MCF‐7 cells.